Magazine Cover Image
New edition: Novo vs. KBP: How a $1.3B deal turned into an international legal fight

JAMA Network

Doctor holding mAb
Pharma

Use of banned antibodies remained ubiquitous this winter

The U.S. FDA earlier this year put the kibosh on a pair of monoclonal antibody combo therapies from Eli Lilly and Regeneron. Did states listen?
Fraiser Kansteiner Sep 2, 2022 9:50am